Details

Fluorinated aminopiperidones as non-glutarimide thalidomide analogs : stereodivergent synthesis and validation
ID Adamlje, Boštjan (Author), ID Tomašič, Tihomir (Author), ID Steinebach, Christian (Author), ID Ebeling, Sebastian (Author), ID Herrmann, Alexander (Author), ID Hartmann, Marcus D. (Author), ID Horner, Jessica L. (Author), ID Bhadresha, Kinjal (Author), ID Sosič, Izidor (Author), ID Cotman, Andrej Emanuel (Author)

.pdfPDF - Presentation file, Download (917,12 KB)
MD5: D31E5660302CF097A57FADF625C2F20C
URLURL - Source URL, Visit https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.70360 This link opens in a new window

Abstract
The glutarimide fragment is a key pharmacophore in cereblon-binding immunomodulatory drugs and proteolysis-targeting chimeras, yet exploration of non-glutarimide scaffolds remains limited. Here, we report the design, synthesis, and evaluation of fluorinated aminopiperidones as three-dimensional, non-glutarimide thalidomide analogs. By replacing a single glutarimide carbonyl with a stereogenic C$^*$–CF$_{3}$ unit, we accessed a previously underexplored chemical space encompassing all regio- and diastereomeric variants of 3- and 5-phthalimido-6-trifluoromethyl-2-piperidones. Stereocontrolled synthetic routes enabled reliable control over relative configurations, and two-dimensional NMR provided unambiguous structural assignment. Experimental profiling of CF$_{3}$-piperidones relative to glutarimides revealed improved aqueous solubility despite increased logD and enhanced membrane interaction characteristics, without substantial changes in plasma protein binding, consistent with sp$^3$ enrichment and escape-from-flatland principles. To assess whether cereblon recognition is retained after carbonyl-to-C$^*$–CF$_{3}$ replacement, the compounds were evaluated by microscale thermophoresis. No measurable cereblon binding was detected for the fluorinated aminopiperidones. Docking studies, performed to rationalize this lack of affinity, suggested disruption of key cereblon–ligand interactions and unfavorable binding poses following carbonyl-to-C$^*$–CF$_{3}$ substitution. Several CF$_{3}$-piperidones, particularly tetrafluorophthalimide derivatives, exhibited potent anti-angiogenic activity in vitro and ex vivo, indicating a cereblon-independent mechanism.

Language:English
Keywords:bioisosterism, diastereoselectivity, drug design, fluorine, PROTAC
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:15 str.
Numbering:Vol. 21, iss. 13, art. e70360
PID:20.500.12556/RUL-185196 This link opens in a new window
UDC:615.4:54
ISSN on article:1860-7187
DOI:10.1002/cmdc.70360 This link opens in a new window
COBISS.SI-ID:284004099 This link opens in a new window
Publication date in RUL:28.07.2026
Views:32
Downloads:21
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:ChemMedChem
Shortened title:ChemMedChem
Publisher:Wiley-VCH-Verl..
ISSN:1860-7187
COBISS.SI-ID:519053337 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:bioizosterizem, diastereoselektivnost, načrtovanje zdravil, fluor, PROTAC, zdravila, farmacevtska kemija

Projects

Funder:Other - Other funder or multiple funders
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-50023
Name:3DfluorCO - Tridimenzionalni fluor-vsebujoči bioizosteri karbonila: asimetrična sinteza in validacija

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-50037
Name:Razvoj selektivnih razgrajevalcev CDK1 za zdravljenje T-celičnih malignih obolenj

Funder:Other - Other funder or multiple funders
Funding programme:University of Ljubljana
Project number:SN-ZRD/22-27/510
Name:University of Ljubljana start-upprogramme

Funder:Other - Other funder or multiple funders
Project number:530691087
Name:Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Acronym:DFG

Funder:Other - Other funder or multiple funders
Project number:552374678
Name:Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Acronym:DFG

Funder:Other - Other funder or multiple funders
Project number:ZIA SC 006538
Name:National Institutes of Health Intramural Research Program of the National Cancer Institute, Center for Cancer Research

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back